Daniel Smith

Vice President, Translational Medicine | Early Clinical Development

Role
Vice President, Translational Medicine at Alkermes
Location
Boston, MA, US
LinkedIn followers
500 followers

About Daniel Smith

Pharmaceutical R&D leader dedicated to the discovery and development of innovative therapeutics for psychiatric, neurological and rare diseases. My passion and areas of greatest expertise are neuroscience translational medicine and early clinical development strategy, planning and execution. I strive to deliver new medicines through cohesive, evidence-based scientific strategies that start in discovery and carry forward through development, product registration and commercial differentiation.

Experience

  1. Vice President, Translational Medicine

    Alkermes

    Mar 2025 — Present · Waltham, MA, US

    Creating and executing translational medicine strategies to deliver novel treatments, including alixorexton, ALKS 7290, ALKS 4510 and others, for neurological, psychiatric and rare diseases. My group collaborates intimately with cross-functional R&D teams, executive leadership and external experts to create detailed research and clinical development strategies and plans based in strong science and informed by the voice of the patient, unmet healthcare needs and commercial opportunity. We strive for logical translation from discovery through development and commercialization.

Education

  • Purdue University

    Ph.D., Psychobiology (now Neuroscience)

  • Eli Lilly and Company

    Postdoctoral Research Fellow, Neuroscience Discovery Research

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Daniel Smith — Vice President, Translational Medicine at Alkermes in Boston, MA, US | Unifers